Biotechnology & Bioengineering Research
This is a new, open access, peer-reviewed international journal and currently accepting articles for publication covered under the scope of this journal. Please review Aims and Scope for the journal to learn more. Initial editorial decision including peer-review comments will be provided within 15 days after first draft submission.
Students are encouraged to submit their research for publication. We are currently offering waivers for publication, based on the availability of funds. Waivers are also available for researchers from low and middle-income countries. Please review our Editorial Policies and Article Processing for applicable publication fees. Please submit your request for waivers using our Contact form or by sending us an email at editorial@egeriapublishing.com.
All articles will be indexed and archived after five articles, according to our Indexing and Archiving Policies.
Biotechnology & Bioengineering Research is an international, peer-reviewed, and open access journal. The journal aims to publish high quality and cutting-edge research that utilizes biological systems to create different products for technological and medical advancements.
Biotechnology & Bioengineering Research accepts articles that describe methodologies, literature reviews, comprehensive analyses, and opinions across all therapeutic areas in health outcomes. The journal considers papers for publication based on their novelty, their immediate or future impact as well as their contribution to the advancement of:
- Medical biotechnology
- Biomaterials
- Biosensors
- Biofuels
- Environmental biotechnology
- Biocatalysis
- Bioinformatics related to genetic and genomic techniques
Biotechnology & Bioengineering Research accepts the following types of manuscripts for publication:
- Commentaries
- Conference Proceedings
- Editorials
- Expert Opinions
- Letters to the Editor
- Methodology
- Original research articles
- Perspectives
- Reviews
- Short Reports
Marc Blondel
Université de Bretagne Occidentale, France
Matthew DeLisa
Cornell University, United States
Masahiro Goto
Kyushu University, Japan
Xiaokun Li
Wenzhou Medical University, China
Anne Robinson
Tulane University, United States
John Woodley
Technical University of Denmark, Denmark
Bang-Ce Ye
East China University of Science and Technology, China
Spencer Shorte
Institut Pasteur, France
Nektarios Tavernarakis
Medical School of the University of Crete, Greece
Jens Nielsen
Chalmers University of Technology, Sweden
For general guidelines on manuscript organization and preparation, please visit Author Guidelines page. We strongly encourage you to review our Editorial Policies before submitting your manuscript.
All manuscripts reporting studies with human participants must indicate approval from institutional review board approval for the study protocol and that informed consent from all study participants.
Egeria Publishing has partnered with Manticore to provide English editing service for all authors. If you wish to use this service, please email contact@manticore.solutions to receive a free quote and a 15% discount on all manuscript editing services.
Please review copyright agreements before submitting your manuscript.
Additional requirements for manuscript preparation
Abstracts
Abstracts are required for Methodology, Original Research, Perspectives, Reviews, and Short Reports. Abstracts should be limited to 300 words and should not contain any references or citations. Abstracts should be structured into the following sections:
- Background & Objectives
- Methods
- Results
- Conclusions & Implications
Methodology, Original Research, Perspectives, Conference Proceedings, and Reviews should be between 3,000-7,000 words, excluding title page, abstract, figures/tables, references, and supplementary materials. Commentaries, Short Reports, Editorials, Expert Opinions, and Letters to the Editor should be between 1,000-3,000 words. All content should be single-spaced with minimum 10- to 12-point Times New Roman, Arial, Helvetica, or Verdana font.
References
All in-text citations and references must use American Medical Association (AMA or JAMA) style. We strongly recommend using a referencing software, such as EndNote, RefWorks, or Mendeley for references. Footnotes are not permitted in the manuscript. You may move the information from footnotes into the main body of the manuscript or into the reference list, as appropriate.
Egeria Publishing uses Open Access for publishing. Your manuscripts are peer-reviewed and the decision is made based on the suggestions of reviewers. The corresponding or submitting author will receive an invoice for Article Processing Charges (APC) once the manuscript is accepted for publication.
Your research articles are published electronically and are freely available to download from our website at any time. Authors who wish to submit the article under CC-BY-NC-ND license may use the published material for non-commercial uses. Published material submitted under CC-BY license may be used for commercial purposes.
Publication Fees
The gold open access publication fee for this journal is USD 980 / GBP 745 / EUR 843, excluding taxes. Editorials and Expert Opinions are by invitation only and are free of charge.
Waiver of Charges
Authors living in low and middle income countries are encouraged to publish their manuscripts with Egeria Publishing. We will work with you to discount the cost of the publishing and to showcase your scholarly work. Discounts and waivers are based on the current availability of funds for fee waivers. Discounts will be applied, if you accept the discounted price offered to you at the time of the submission. No further discounts will be applied to the finalized charges. Discounts may not be combined and where multiple discounts are available the one most favorable to the author will apply. For more information, please review Article Processing Charges.
Once your manuscript has been accepted for publication, Article Processing Charges for the article are due by the date listed on the invoice. Egeria Publishing will not issue any refunds.